Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer

BACKGROUND: Pancreatic cancer (PAC) is one of the most malignant cancer types and immunotherapy has emerged as a promising treatment option. PAC cells undergo metabolic reprogramming, which is thought to modulate the tumor microenvironment (TME) and affect immunotherapy outcomes. However, the metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yongdong, Wang, Ronglin, Shi, Jingjie, Yang, Cheng, Ma, Peixiang, Min, Jie, Zhao, Ting, Hua, Lei, Song, Yang, Li, Junqiang, Su, Haichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533800/
https://www.ncbi.nlm.nih.gov/pubmed/37739440
http://dx.doi.org/10.1136/jitc-2023-007466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533800/
https://www.ncbi.nlm.nih.gov/pubmed/37739440
http://dx.doi.org/10.1136/jitc-2023-007466

Ejemplares similares